Literature DB >> 34129146

Development of Gelucire® 48/16 and TPGS Mixed Micelles and Its Pellet Formulation by Extrusion Spheronization Technique for Dissolution Rate Enhancement of Curcumin.

Umesh K Shinde1, Dilipkumar G Suryawanshi1, Purnima D Amin2.   

Abstract

The oral bioavailability of curcumin is limited, attributed to its low solubility or dissolution and poor absorption. Herein, the study describes formulation of curcumin-loaded mixed micelles of Gelucire® 48/16 and TPGS for its dissolution rate enhancement. Curcumin was dispersed in these molten lipidic surfactants which was then adsorbed on carrier and formulated as pellets by extrusion spheronization. Critical micelle concentration (CMC) of binary mixture of Gelucire® 48/16 and TPGS was lower than their individual CMC demonstrating the synergistic behavior of mixture. Thermodynamic parameters like partition coefficient and Gibbs free energy of solubilization indicated that mixed micelles were more efficient than micelles of its individual components in curcumin solubilization. Dynamic light scattering (DLS) suggested slight increase in micellar size of mixed micelles than its components suggesting curcumin loading in mixed micelles. Fourier transform infrared spectroscopy (FTIR) revealed that phenolic hydroxyl group interacts with lipids which contribute to its enhanced solubility. Furthermore, the differential scanning calorimetry (DSC) and X-ray diffraction (XRD) study indicated the conversion of crystalline curcumin into amorphous form. In the pellet formulation, Gelucire® 48/16 acted as a binder and eliminated the requirement of additional binder. Microcrystalline cellulose (MCC) forms wet mass and retards the release of curcumin from pellets. Increase in concentration of water-soluble diluent increased drug release. The optimized formulation released more than 90% drug and maintains supersaturation level of curcumin for 2 h. Thus, mixed micellar system was effective delivery system for curcumin while pellet formulation is an interesting formulation strategy consisting semi-solid lipids.

Entities:  

Keywords:  Curcumin; Gelucire® 48/16; TPGS; critical micelle concentration (CMC); mixed micelles

Year:  2021        PMID: 34129146     DOI: 10.1208/s12249-021-02032-8

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  27 in total

1.  The pharmacology of curcumin: is it the degradation products?

Authors:  Liang Shen; Hong-Fang Ji
Journal:  Trends Mol Med       Date:  2012-03-01       Impact factor: 11.951

2.  Evaluating potential of curcumin loaded solid lipid nanoparticles in aluminium induced behavioural, biochemical and histopathological alterations in mice brain.

Authors:  Vandita Kakkar; Indu Pal Kaur
Journal:  Food Chem Toxicol       Date:  2011-08-25       Impact factor: 6.023

Review 3.  Role of curcumin in the management of pathological pain.

Authors:  Jia Sun; Fei Chen; Cody Braun; Ya-Qun Zhou; Heike Rittner; Yu-Ke Tian; Xiu-Yu Cai; Da-Wei Ye
Journal:  Phytomedicine       Date:  2018-04-17       Impact factor: 5.340

Review 4.  Curcumin, the golden spice in treating cardiovascular diseases.

Authors:  Hong Li; Antoni Sureda; Hari Prasad Devkota; Valeria Pittalà; Davide Barreca; Ana Sanches Silva; Devesh Tewari; Suowen Xu; Seyed Mohammad Nabavi
Journal:  Biotechnol Adv       Date:  2019-02-01       Impact factor: 14.227

5.  A systemic review on the antioxidant and anti-inflammatory effects of resveratrol, curcumin, and dietary nitric oxide supplementation on human cardiovascular health.

Authors:  Melissa J Banez; Matthew I Geluz; Anjali Chandra; Tesnim Hamdan; Olivia S Biswas; Nathan S Bryan; Ernst R Von Schwarz
Journal:  Nutr Res       Date:  2020-03-10       Impact factor: 3.315

6.  Curcumin loaded mixed micelles composed of Pluronic P123 and F68: preparation, optimization and in vitro characterization.

Authors:  Liyan Zhao; Jianchao Du; Yuwei Duan; Ya'ni Zang; Huaisong Zhang; Chunfen Yang; Fengliang Cao; Guangxi Zhai
Journal:  Colloids Surf B Biointerfaces       Date:  2012-04-24       Impact factor: 5.268

Review 7.  Curcumin as tyrosine kinase inhibitor in cancer treatment.

Authors:  A Golonko; H Lewandowska; R Świsłocka; U T Jasińska; W Priebe; W Lewandowski
Journal:  Eur J Med Chem       Date:  2019-07-15       Impact factor: 6.514

8.  Curcumin activates AMPK and suppresses gluconeogenic gene expression in hepatoma cells.

Authors:  Teayoun Kim; Jessica Davis; Albert J Zhang; Xiaoming He; Suresh T Mathews
Journal:  Biochem Biophys Res Commun       Date:  2009-08-08       Impact factor: 3.575

9.  Curcuminoids-loaded liposomes in combination with arteether protects against Plasmodium berghei infection in mice.

Authors:  N P Aditya; Geetanjali Chimote; Karthigayan Gunalan; Rinti Banerjee; Swati Patankar; Basavaraj Madhusudhan
Journal:  Exp Parasitol       Date:  2012-05-03       Impact factor: 2.011

10.  Curcuminoid analogs with potent activity against Trypanosoma and Leishmania species.

Authors:  Chatchawan Changtam; Harry P de Koning; Hasan Ibrahim; M Sohail Sajid; Matthew K Gould; Apichart Suksamrarn
Journal:  Eur J Med Chem       Date:  2009-11-24       Impact factor: 6.514

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.